{"Abstract": [0], "Strategies": [1], "to": [2, 22, 36], "therapeutically": [3], "target": [4], "the": [5, 23, 27, 42, 46, 75, 83, 104, 108, 114, 127], "tumor": [6, 31], "microenvironment": [7], "(TME)": [8], "have": [9, 52], "emerged": [10], "as": [11], "a": [12, 100, 111], "promising": [13], "approach": [14], "for": [15], "cancer": [16], "treatment": [17], "in": [18, 29, 62, 92], "recent": [19], "years": [20], "due": [21], "critical": [24], "roles": [25], "of": [26, 82, 103, 113, 121], "TME": [28, 87], "regulating": [30], "progression": [32], "and": [33, 68, 74, 89, 125, 129], "modulating": [34], "response": [35], "standard-of-care": [37], "therapies.": [38], "Here,": [39], "we": [40], "summarize": [41], "current": [43, 105], "knowledge": [44], "regarding": [45], "most": [47], "advanced": [48], "TME-directed": [49], "therapies,": [50, 88], "which": [51], "either": [53], "been": [54], "clinically": [55], "approved": [56], "or": [57], "are": [58], "currently": [59], "being": [60], "evaluated": [61], "trials,": [63], "including": [64], "immunotherapies,": [65], "antiangiogenic": [66], "drugs,": [67], "treatments": [69], "directed": [70], "against": [71], "cancer-associated": [72], "fibroblasts": [73], "extracellular": [76], "matrix.": [77], "We": [78], "also": [79], "discuss": [80], "some": [81], "challenges": [84, 128], "associated": [85], "with": [86, 118], "future": [90, 130], "perspectives": [91], "this": [93], "evolving": [94], "field.": [95], "Significance:": [96], "This": [97], "review": [98], "provides": [99], "comprehensive": [101], "analysis": [102], "therapies": [106], "targeting": [107], "TME,": [109], "combining": [110], "discussion": [112], "underlying": [115], "basic": [116], "biology": [117], "clinical": [119], "evaluation": [120], "different": [122], "therapeutic": [123], "approaches,": [124], "highlighting": [126], "perspectives.": [131]}